Li Xueqian, Tang Mengmeng, Yao Xingfeng, Zhang Nan, Fan Jianfeng, Zhou Nan, Sun Qiang, Chen Zhi, Meng Qun, Lei Lei, Zhang Hejia, Ling Chen, Hua Lin, Chen Xiangmei, Liu Xiaorong
Department of Nephrology, Beijing Children's Hospital, Capital Medical University, Beijing, 100045, China.
Beijing Children's Hemodialysis Center, Beijing, 100045, China.
Clin Exp Nephrol. 2019 Dec;23(12):1382-1390. doi: 10.1007/s10157-019-01777-8. Epub 2019 Aug 29.
There is controversy over whether IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis (HSPN) are the same diseases. This study focuses on the clinicopathological comparison between HSPN and IgAN in children.
Children with IgAN and HSPN who had a diagnostic renal biopsy were enrolled. This study collected the clinical data of patients at biopsy, re-evaluated the pathological lesions of patients according to the Oxford Classification (MEST-C), and made a retrospective comparison between IgAN and HSPN on different stratifications of the course (Tc) and proteinuria.
A total of 142 children with IgAN and 57 children with HSPN were enrolled. Various stratification showed the same result, which suggested that IgAN showed more mesangial proliferation (M). HSPN showed more segmental glomerulosclerosis in the Tc > 12 m group than IgAN (S 60.0% vs. 9.10%, P = 0.008). In the non-nephrotic-range and nephrotic-range proteinuria group, there were no significant differences in MEST-C scores between IgAN and HSPN.
M is more common in IgAN. HSPN had more S than IgAN over the course of more than 12 months. These results indicate the differences in the pathogenesis in IgAN and HSPN. We propose early biopsy and active treatment of HSPN within 12 months to delay the development of chronic lesions.
IgA肾病(IgAN)和过敏性紫癜性肾炎(HSPN)是否为同一种疾病存在争议。本研究聚焦于儿童HSPN和IgAN的临床病理比较。
纳入经诊断性肾活检的IgAN和HSPN患儿。本研究收集了患者活检时的临床资料,根据牛津分类法(MEST-C)重新评估患者的病理病变,并对IgAN和HSPN在病程(Tc)和蛋白尿的不同分层上进行回顾性比较。
共纳入142例IgAN患儿和57例HSPN患儿。各种分层显示出相同的结果,即IgAN显示出更多的系膜增生(M)。在Tc>12个月组中,HSPN比IgAN表现出更多的节段性肾小球硬化(S:60.0%对9.10%,P = 0.008)。在非肾病范围和肾病范围蛋白尿组中,IgAN和HSPN的MEST-C评分无显著差异。
M在IgAN中更常见。在超过12个月的病程中,HSPN比IgAN有更多的S。这些结果表明IgAN和HSPN发病机制的差异。我们建议对HSPN在12个月内进行早期活检和积极治疗,以延缓慢性病变的发展。